Sentinel Trust’s Novo Nordisk NVO Stock Holding History

Sentinel Trust’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2M	Sell	41,672 -4,566	-10%	-$196K	0.18%	57
2026 Q1	$1.7M	Hold	46,238	–	–	0.17%	59
2025 Q4	$2.35M	Hold	46,238	–	–	0.23%	41
2025 Q3	$2.57M	Buy	46,238 +2,066	+5%	+$121K	0.26%	39
2025 Q2	$3.05M	Hold	44,172	–	–	0.33%	39
2025 Q1	$3.07M	Sell	44,172 -194	-0.4%	-$16K	0.36%	37
2024 Q4	$3.82M	Buy	44,366 +194	+0.4%	+$21K	0.44%	33
2024 Q3	$5.26M	Hold	44,172	–	–	0.6%	31
2024 Q2	$6.3M	Hold	44,172	–	–	0.78%	25
2024 Q1	$5.67M	Hold	44,172	–	–	0.73%	25
2023 Q4	$4.57M	Hold	44,172	–	–	0.6%	29
2023 Q3	$4.02M	Buy	44,172 +1,672	+4%	+$147K	0.57%	30
2023 Q2	$3.44M	Hold	42,500	–	–	0.47%	30
2023 Q1	$3.38M	Buy	+42,500	New	+$3.01M	0.48%	28

Other funds holding NVO

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

OFA

Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Sentinel Trust's NVO Position: Q2 2026 in Review

Sentinel Trust reduced its Novo Nordisk (NVO) stake by 9.9% in Q2 2026, selling an estimated $196K and leaving 41,672 shares worth $2M. The position accounts for 0.18% of the portfolio, ranked #57.

Sentinel Trust first reported a position in NVO in Q1 2023 and has held it in 14 quarters since. The position peaked at $6.3M in Q2 2024. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Sentinel Trust held 41,672 shares of Novo Nordisk worth $2M as of Q2 2026.
Sentinel Trust sold 4,566 Novo Nordisk shares in Q2 2026, an estimated $196K.
Novo Nordisk made up 0.18% of Sentinel Trust's portfolio in Q2 2026, its #57 holding.
Sentinel Trust first reported a position in Novo Nordisk in Q1 2023 and has held it in 14 quarters since.
Sentinel Trust's Novo Nordisk position peaked at $6.3M in Q2 2024.
387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Sentinel Trust's 13F filing for Q2 2026, filed 13 Jul 2026.